- Home
- CRBU vs RDCM Comparison
CRBU vs RDCM Comparison
Compare CRBU & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- RDCM
- Stock Information
- Founded
- CRBU 2011
- RDCM 1985
- Country
- CRBU United States
- RDCM Israel
- Employees
- CRBU N/A
- RDCM N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- RDCM Computer peripheral equipment
- Sector
- CRBU Health Care
- RDCM Technology
- Exchange
- CRBU Nasdaq
- RDCM Nasdaq
- Market Cap
- CRBU 188.8M
- RDCM 203.7M
- IPO Year
- CRBU 2021
- RDCM 1997
- Fundamental
- Price
- CRBU $1.93
- RDCM $13.26
- Analyst Decision
- CRBU Strong Buy
- RDCM Strong Buy
- Analyst Count
- CRBU 3
- RDCM 1
- Target Price
- CRBU $6.67
- RDCM $18.00
- AVG Volume (30 Days)
- CRBU 1.0M
- RDCM 63.9K
- Earning Date
- CRBU 08-12-2025
- RDCM 08-13-2025
- Dividend Yield
- CRBU N/A
- RDCM N/A
- EPS Growth
- CRBU N/A
- RDCM 79.61
- EPS
- CRBU N/A
- RDCM 0.56
- Revenue
- CRBU $9,121,000.00
- RDCM $66,334,000.00
- Revenue This Year
- CRBU $9.23
- RDCM $18.07
- Revenue Next Year
- CRBU N/A
- RDCM $11.52
- P/E Ratio
- CRBU N/A
- RDCM $23.86
- Revenue Growth
- CRBU N/A
- RDCM 18.18
- 52 Week Low
- CRBU $0.66
- RDCM $9.23
- 52 Week High
- CRBU $3.00
- RDCM $15.98
- Technical
- Relative Strength Index (RSI)
- CRBU 56.96
- RDCM 50.02
- Support Level
- CRBU $1.80
- RDCM $13.14
- Resistance Level
- CRBU $2.16
- RDCM $13.78
- Average True Range (ATR)
- CRBU 0.14
- RDCM 0.54
- MACD
- CRBU 0.00
- RDCM 0.02
- Stochastic Oscillator
- CRBU 73.28
- RDCM 40.45
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.